Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates

Key facts

Sponsor

Lawrence Engmann

Principal Investigator

Lawrence Engmann, MD

UConn Health

Intervention

Microfluidics chamber(device)

Enrollment

150 target

Eligibility

18-42 years · FEMALE

Timeline

2021 – 2022

Study locations (1)

• The Center for Advanced Reproductive Services, Farmington, Connecticut, United States

Collaborators

The Center for Advanced Reproductive Services, P.C. · ZyMot Fertility

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Genetic infertility

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT07369362
  To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
  MotilityCount aps
• ENROLLING BY INVITATIONNCT06419127
  Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing
  Gattaca Genomics
• RECRUITINGNANCT06023472
  Microfluidic Chip vs Density Gradient Centrifugation on the Euploidy Rate of Pre-implantation Genetic Testing
  Professor Ernest Hung-Yu Ng
• RECRUITINGNANCT06358547
  Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years
  Rigshospitalet, Denmark
• RECRUITINGNANCT06261671
  Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
  ART Fertility Clinics LLC
• RECRUITINGNCT04528498
  Embryo Health Study
  Genomic Prediction Inc.
• RECRUITINGNCT04477863
  Follow-up With Preimplantation Genetic Testing Patients
  Genomic Prediction Inc.
• ACTIVE NOT RECRUITINGNCT00501800
  Genetic Epidemiology of Ovarian Aging
  University of California, San Francisco

See all trials for Genetic infertility →